Paul Knight
Stock Analyst at Keybanc
(3.27)
# 1,166
Out of 4,479 analysts
122
Total ratings
44.79%
Success rate
1.85%
Average return
Main Sectors:
34 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Overweight | $25 → $28 | $21.26 | +31.70% | 6 | Mar 1, 2024 | |
| RGEN Repligen | Maintains: Overweight | $210 → $220 | $120.14 | +83.12% | 7 | Feb 15, 2024 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $440 → $470 | $322.60 | +45.69% | 10 | Feb 13, 2024 | |
| RVTY Revvity | Maintains: Overweight | $110 → $126 | $102.01 | +23.52% | 2 | Feb 2, 2024 | |
| DHR Danaher | Maintains: Overweight | $260 → $290 | $240.41 | +20.63% | 7 | Feb 1, 2024 | |
| CDMO Avid Bioservices | Maintains: Overweight | $20 → $14 | $6.70 | +108.96% | 5 | Dec 8, 2023 | |
| TECH Bio-Techne | Maintains: Overweight | $115 → $80 | $71.24 | +12.30% | 6 | Nov 1, 2023 | |
| TMO Thermo Fisher | Downgrades: Sector Weight | n/a | $533.93 | - | 6 | Oct 26, 2023 | |
| STVN Stevanato Group | Maintains: Overweight | $35 → $37 | $18.00 | +105.56% | 5 | Aug 30, 2023 | |
| TBIO Telesis Bio | Downgrades: Sector Weight | n/a | $3.74 | - | 1 | Aug 11, 2023 | |
| MRVI Maravai LifeSciences Holdings | Downgrades: Sector Weight | n/a | $6.84 | - | 8 | Aug 8, 2023 | |
| CYRX Cryoport | Downgrades: Sector Weight | n/a | $6.18 | - | 7 | Jul 17, 2023 | |
| TKNO Alpha Teknova | Initiates: Sector Weight | n/a | $1.23 | - | 1 | Jul 12, 2023 | |
| LAB Standard BioTools | Initiates: Overweight | $4 | $1.77 | +125.99% | 1 | Jul 12, 2023 | |
| A Agilent Technologies | Downgrades: Sector Weight | n/a | $125.78 | - | 7 | May 24, 2023 | |
| AZTA Azenta | Downgrades: Sector Weight | n/a | $51.53 | - | 3 | May 10, 2023 | |
| HBIO Harvard Bioscience | Maintains: Overweight | $5 → $7 | $2.79 | +150.90% | 4 | Apr 26, 2023 | |
| CTLT Catalent | Downgrades: Sector Weight | n/a | $56.20 | - | 5 | Dec 19, 2022 | |
| AVTR Avantor | Maintains: Overweight | $51 → $40 | $20.58 | +94.36% | 5 | Sep 15, 2022 | |
| XGN Exagen | Maintains: Overweight | $20 → $17 | $1.78 | +855.06% | 5 | May 13, 2022 | |
| BLFS BioLife Solutions | Maintains: Overweight | $60 → $30 | $20.23 | +48.29% | 3 | May 10, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $390 → $300 | $201.48 | +48.90% | 1 | May 5, 2022 | |
| IQV IQVIA Holdings | Maintains: Overweight | $290 → $250 | $207.47 | +20.50% | 1 | Apr 28, 2022 | |
| OCX OncoCyte | Downgrades: Sector Weight | n/a | $2.96 | - | 2 | Mar 14, 2022 | |
| TFX Teleflex | Maintains: Overweight | n/a | $211.25 | - | 1 | Jan 8, 2021 | |
| ICUI ICU Medical | Maintains: Overweight | n/a | $117.53 | - | 1 | Jan 8, 2021 | |
| COO The Cooper Companies | Maintains: Overweight | $92 → $99 | $86.51 | +14.44% | 1 | Jan 8, 2021 | |
| AVNS Avanos Medical | Maintains: Overweight | n/a | $19.50 | - | 1 | Jan 8, 2021 | |
| WAT Waters | Initiates: Sector Weight | n/a | $284.49 | - | 3 | Nov 10, 2020 | |
| VCYT Veracyte | Initiates: Sector Weight | n/a | $21.26 | - | 3 | Nov 10, 2020 | |
| SCND Scientific Industries | Initiates: Sector Weight | n/a | $1.29 | - | 1 | Nov 10, 2020 | |
| MLAB Mesa Laboratories | Initiates: Sector Weight | n/a | $87.73 | - | 1 | Nov 10, 2020 | |
| IDXG Interpace Biosciences | Initiates: Buy | n/a | $1.10 | - | 1 | Apr 15, 2020 | |
| ILMN Illumina | Upgrades: Neutral | n/a | $105.51 | - | 1 | Oct 23, 2017 |
Castle Biosciences
Mar 1, 2024
Maintains: Overweight
Price Target: $25 → $28
Current: $21.26
Upside: +31.70%
Repligen
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $120.14
Upside: +83.12%
West Pharmaceutical Services
Feb 13, 2024
Maintains: Overweight
Price Target: $440 → $470
Current: $322.60
Upside: +45.69%
Revvity
Feb 2, 2024
Maintains: Overweight
Price Target: $110 → $126
Current: $102.01
Upside: +23.52%
Danaher
Feb 1, 2024
Maintains: Overweight
Price Target: $260 → $290
Current: $240.41
Upside: +20.63%
Avid Bioservices
Dec 8, 2023
Maintains: Overweight
Price Target: $20 → $14
Current: $6.70
Upside: +108.96%
Bio-Techne
Nov 1, 2023
Maintains: Overweight
Price Target: $115 → $80
Current: $71.24
Upside: +12.30%
Thermo Fisher
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $533.93
Upside: -
Stevanato Group
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $18.00
Upside: +105.56%
Telesis Bio
Aug 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.74
Upside: -
Maravai LifeSciences Holdings
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $6.84
Upside: -
Cryoport
Jul 17, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $6.18
Upside: -
Alpha Teknova
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $1.23
Upside: -
Standard BioTools
Jul 12, 2023
Initiates: Overweight
Price Target: $4
Current: $1.77
Upside: +125.99%
Agilent Technologies
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $125.78
Upside: -
Azenta
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $51.53
Upside: -
Harvard Bioscience
Apr 26, 2023
Maintains: Overweight
Price Target: $5 → $7
Current: $2.79
Upside: +150.90%
Catalent
Dec 19, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $56.20
Upside: -
Avantor
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $20.58
Upside: +94.36%
Exagen
May 13, 2022
Maintains: Overweight
Price Target: $20 → $17
Current: $1.78
Upside: +855.06%
BioLife Solutions
May 10, 2022
Maintains: Overweight
Price Target: $60 → $30
Current: $20.23
Upside: +48.29%
Charles River Laboratories International
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $201.48
Upside: +48.90%
IQVIA Holdings
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $207.47
Upside: +20.50%
OncoCyte
Mar 14, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $2.96
Upside: -
Teleflex
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $211.25
Upside: -
ICU Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $117.53
Upside: -
The Cooper Companies
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $86.51
Upside: +14.44%
Avanos Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $19.50
Upside: -
Waters
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $284.49
Upside: -
Veracyte
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $21.26
Upside: -
Scientific Industries
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $1.29
Upside: -
Mesa Laboratories
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $87.73
Upside: -
Interpace Biosciences
Apr 15, 2020
Initiates: Buy
Price Target: n/a
Current: $1.10
Upside: -
Illumina
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $105.51
Upside: -